Unknown

Dataset Information

0

COL1A2 p.Gly1066Val variant identified in a Han Chinese family with osteogenesis imperfecta type I.


ABSTRACT: BACKGROUND:Osteogenesis imperfecta (OI), a genetically determined connective tissue disorder, is characterized by increased bone fragility and reduced bone mass. Clinical presentation severity ranges from very mild types with nearly no fractures to intrauterine fractures and perinatal lethality. It can be accompanied by blue sclerae, dentinogenesis imperfecta (DI), hearing loss, muscle weakness, ligament laxity, and skin fragility. This study sought to identify pathogenic gene variants in a four-generation Han Chinese family with OI type I. METHODS:In order to unveil the molecular genetic factors underlying the disease phenotype, whole exome sequencing in a member, with OI type I, of a Han Chinese family from Hunan, China was performed. The variant identified by whole exome sequencing was further tested by Sanger sequencing in the family members. RESULTS:A heterozygous missense variant (NM_000089.3: c.3197G>T; NP_000080.2: p.Gly1066Val) in the collagen type I alpha 2 chain gene (COL1A2) was identified in four patients. It co-segregated with the disease in the family. CONCLUSION:The sequence variant may be a disease-causing factor resulting in abnormal type I procollagen synthesis and leading to OI type I. This finding has significant implications for genetic counseling and clinical monitoring of high-risk families and may be helpful for understanding pathogenic mechanism of OI and developing therapies.

SUBMITTER: Wang M 

PROVIDER: S-EPMC6503011 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

COL1A2 p.Gly1066Val variant identified in a Han Chinese family with osteogenesis imperfecta type I.

Wang Mingyuan M   Guo Yi Y   Rong Pengfei P   Xu Hongbo H   Gong Lina L   Deng Hao H   Yuan Lamei L  

Molecular genetics & genomic medicine 20190304 5


<h4>Background</h4>Osteogenesis imperfecta (OI), a genetically determined connective tissue disorder, is characterized by increased bone fragility and reduced bone mass. Clinical presentation severity ranges from very mild types with nearly no fractures to intrauterine fractures and perinatal lethality. It can be accompanied by blue sclerae, dentinogenesis imperfecta (DI), hearing loss, muscle weakness, ligament laxity, and skin fragility. This study sought to identify pathogenic gene variants i  ...[more]

Similar Datasets

| S-EPMC7507304 | biostudies-literature
| S-EPMC5548966 | biostudies-literature
| S-EPMC5558703 | biostudies-literature
| S-EPMC5568266 | biostudies-literature
| S-EPMC9482389 | biostudies-literature
| S-EPMC10495319 | biostudies-literature
| S-EPMC7815406 | biostudies-literature
| S-EPMC3748067 | biostudies-literature
2010-11-01 | E-GEOD-21958 | biostudies-arrayexpress
| S-EPMC4128632 | biostudies-literature